Hydroxychloroquine BIG DATA Benefit in Ambulatory COVID-19 Treatment Protocols: Dr Peter McCullough

Internist and cardiologist Dr. Peter McCullough appears on France-Soir with journalist Xavier Albert to discuss very large studies of hydroxychloroquine in multidrug treatment protocols for COVID-19. McCullough says even if trials are not randomized, survival always matter. Meaning patients who took hydroxychloroquine survived, and sadly some who did not take HCQ died with SARS-CoV-2 infection. Courtesy France-Soir, November 28, 2023.

Citations

Brouqui P, Million M, Parola P, Mccullough PA, Raoult D. Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients. New Microbes New Infect. 2023 Oct 30;55:101188. doi: 10.1016/j.nmni.2023.101188. PMID: 38024333; PMCID: PMC10651676.

McCullough PA, Stricker RB, Risch HA. Role of hydroxychloroquine in multidrug treatment of COVID-19. Rev Cardiovasc Med. 2021 Sep 24;22(3):545-546. doi: 10.31083/j.rcm2203063. PMID: 34565055.